Brain-derived neurotrophic factor activation of TrkB protects neuroblastoma cells from chemotherapy-induced apoptosis via phosphatidylinositol 3′-kinase pathway

Cancer Research

Volumn 62, Issue 22, 2002, Pages 6756-6763

  Jaboin, Jerry ^a,d   Kim, Chong Jai ^b   Kaplan, David R ^c   Thiele, Carol J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Seoul National University College of Medicine   (South Korea)

^c MCGILL UNIVERSITY   (Canada)

^d HOWARD UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; ANTINEOPLASTIC AGENT; CISPLATIN; DOXORUBICIN; ETOPOSIDE; K 252A; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; NERVE GROWTH FACTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN TYROSINE KINASE INHIBITOR; RECOMBINANT BRAIN DERIVED NEUROTROPHIC FACTOR; TETRACYCLINE; VINBLASTINE;

APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CELL DEATH; CELL SURVIVAL; CHEMOSENSITIVITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; PRIORITY JOURNAL; TUMOR CELL CULTURE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; APOPTOSIS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CISPLATIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; ENZYME ACTIVATION; ETOPOSIDE; HUMANS; NEUROBLASTOMA; PROMOTER REGIONS (GENETICS); RATS; RECEPTOR, TRKB; SIGNAL TRANSDUCTION; TETRACYCLINE; TRANSFECTION; TUMOR CELLS, CULTURED; VINBLASTINE;

EID: 0037112455     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Brodeur, G. M., Pritchard, J., Berthold, F., Carlsen, N. L., Castel, V., Castelberry, R. P., De Bernardi, B., Evans, A. E., Favrot, M., Hedborg, F., and et al. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J. Clin. Oncol., 11: 1466-1477, 1993
2. Nakagawara, A., Arima-Nakagawara, M., Scavarda, N. J., Azar, C. G., Cantor, A. B., and Brodeur, G. M. Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma. N. Engl. J. Med., 328: 847-854, 1993
3. Brodeur, G. M., Maris, J. M., Yamashiro, D. J., Hogarty, M. D., and White, P. S. Biology and genetics of human neuroblastomas. J. Pediatr. Hematol. Oncol., 19: 93-101, 1997
4. Matsumoto, K., Wada, R. K., Yamashiro, J. M., Kaplan, D. R., and Thiele, C. J. Expression of brain-derived neurotrophic factor and p145TrkB affects survival, differentiation, and invasiveness of human neuroblastoma cells. Cancer Res., 55: 1798-806, 1995
5. Feng, X., Jiang, H., Baik, J. C., Edgar, C., and Eide, F. F. BDNF dependence in neuroblastoma. J. Neurosci. Res., 64: 355-363, 2001
6. Lucarelli, E., Kaplan, D., and Thiele, C. J. Activation of trk-A but not trk-B signal transduction pathway inhibits growth of neuroblastoma cells. Eur. J. Cancer, 33: 2068-2070, 1997
7. Scala, S., Wosikowski, K., Giannakakou, P., Valle, P., Biedler, J. L., Spengler, B. A., Lucarelli, E., Bates, S. E., and Thiele, C. J. Brain-derived neurotrophic factor protects neuroblastoma cells from vinblastine toxicity. Cancer Res., 56: 3737-3742, 1996
8. Middlemas, D. S., Kihl, B. K., Zhou, J., and Zhu, X. Brain-derived neurotrophic factor promotes survival and chemoprotection of human neuroblastoma cells. J. Biol. Chem., 274: 16451-60, 1999
9. Smeyne, R. J., Klein, R., Schnapp, A., Long, L. K., Bryant, S., Lewin, A., Lira, S. A., and Barbacid, M. Severe sensory and sympathetic neuropathies in mice carrying a disrupted Trk/NGF receptor gene. Nature (Lond.), 368: 246-249, 1994
10. Miller, F. D., and Kaplan, D. R. Neurotrophin signalling pathways regulating neuronal apoptosis. Cell Mol. Life Sci., 58: 1045-1053, 2001
11. Persson, H., and Ibanez, C. F. Role and expression of neurotrophins and the trk family of tyrosine kinase receptors in neural growth and rescue after injury. Curr. Opin. Neurol. Neurosurg., 6: 11-18, 1993
12. Heumann, R. Neurotrophin signalling. Curr. Opin. Neurobiol., 4: 668-679, 1994
13. Johnson, E. M., Jr. Destruction of the sympathetic nervous system in neonatal rats and hamsters by vinblastine: Prevention by concomitant administration of nerve growth factor. Brain Res., 141: 105-118, 1978
14. Shimohama, S., Tamura, Y., Akaike, A., Tsukahara, T., Ohara, O., Watanabe, S., and Kimura, J. Brain-derived neurotrophic factor pretreatment exerts a partially protective effect against glutamate-induced neurotoxicity in cultured rat cortical neurons. Neurosci. Lett., 164: 55-58, 1993
15. Wozniak, W. Brain-derived neurotrophic factor (BDNF): Role in neuronal development and survival. Folia Morphol (Warsz)., 52: 173-181, 1993
16. Lindholm, D., Dechant, G., Heisenberg, C. P., and Thoenen, H. Brain-derived neurotrophic factor is a survival factor for cultured rat cerebellar granule neurons and protects them against glutamate-induced neurotoxicity. Eur J. Neurosci., 5: 1455-1464, 1993
17. Ventimiglia, R., Mather, P. E., Jones, B. E., and Lindsay, R. M. The neurotrophins BDNF. NT-3 and NT-4/5 promote survival and morphological and biochemical differentiation of striatal neurons in vitro. Eur J. Neurosci., 7: 213-222, 1995
18. Acheson, A., Conover, J. C. Fandl J. P., DeChiara, T. M., Russell, M., Thadani, A., Squinto, S. P., Yancopoulos, G. D., and Lindsay, R. M. A BDNF autocrine loop in adult sensory neurons prevents cell death. Nature (Lond.), 374: 450-453, 1995
19. Wang, W., Salvaterra, P. M., Loera, S., and Chiu, A. Y. Brain-derived neurotrophic factor spares choline acetyltransferase mRNA following axotomy of motor neurons in vivo. J. Neurosci. Res., 47: 134-143, 1997
20. Kume, T., Kouchiyama, H., Kaneko, S., Maeda, T., Akaike, A., Shimohama, S., Kihara, T., Kimura, J., Wada, K., and Koizumi, S. BDNF prevents NO mediated glutamate cytotoxicity in cultured cortical neurons. Brain Res., 756: 200-204, 1997
21. Cheng, B., and Mattson, M. P. NT-3 and BDNF protect CNS neurons against metabolic/excitotoxic insults. Brain Res., 640: 56-67, 1994
22. Courtney, M. J., Akerman, K. E., and Coffey, E. T. Neurotrophins protect cultured cerebellar granule neurons against the early phase of cell death by a two-component mechanism. J. Neurosci., 17: 4201-4211, 1997
23. Kim, C. J., Matsuo, T., Lee, K. H., and Thiele, C. J. Up-regulation of insulin-like growth factor-II expression is a feature of TrkA but not TrkB activation in SH-SY5Y neuroblastoma cells. Am. J. Pathol., 155: 1661-1670, 1999
24. Thiele, C., Cohen, P., and Israel, M. Regulation of c-myb expression in human neuroblastoma cells during retinoic acid induced differentiation. Mol. Cell. Biol., 8: 1677-1683, 1988
25. Kaplan, D. R., Matsumoto, K., Lucarelli, E., and Thiele, C. J. Induction of TrkB by retinoic acid mediates biologic responsiveness to BDNF and differentiation of human neuroblastoma cells. Eukaryotic Signal Transduction Group. Neuron, 11: 321-331, 1993
26. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods, 65: 55-63, 1983
27. Kaplan, D. R. Studying signal transduction in neuronal cells: The Trk/NGF system. Prog. Brain Res., 117: 35-46, 1998
28. Lindvall, O., Kokaia, Z., Bengzon, J., Elmer, E., and Kokaia, M. Neurotrophins and brain insults. Trends Neurosci., 17: 490-496, 1994
29. Cortazzo, M. H., Kassis, E. S., Sproul, K. A., and Schor, N. F. Nerve growth factor (NGF)-mediated protection of neural crest cells from antimitotic agent-induced apoptosis: The role of the low-affinity NGF receptor. J. Neurosci., 16: 3895-3899, 1996
30. DuBois, S. G., Kalika, Y., Lukens, J. N., Brodeur, G. M., Seeger, R. C., Atkinson, J. B., Haase. G. M., Black, C. T., Perez, C., Shimada, H., Gerbing, R., Stram, D. O., and Matthay, K. K. Metastatic sites in stage IV and IVS neuroblastoma correlate with age, tumor biology, and survival. J. Pediatr. Hematol. Oncol., 21: 181-189, 1999
31. Yamashiro, T., Fukunaga, T., Yamashita, K., Kobashi, N., and Takano-Yamamoto, T. Gene and protein expression of brain-derived neurotrophic factor and TrkB in bone and cartilage. Bone, 28: 404-409, 2001
32. Bhogate, B. M., Samuel, A. M., and Ramanathan, P. Bone scans in neuroblastoma. Indian J. Cancer, 30: 5-9, 1993
33. Bhave, S. V., Ghoda, L., and Hoffman, P. L. Brain-derived neurotrophic factor mediates the anti-apoptotic effect of NMDA in cerebellar granule neurons: Signal transduction cascades and site of ethanol action. J. Neurosci., 19: 3277-3286, 1999
34. Han, B. H., and Holtzman, D. M. BDNF protects the neonatal brain from hypoxic-ischemic injury in vivo via the ERK pathway. J. Neurosci., 20: 5775-5781, 2000
35. Skaper, S. D., Floreani, M., Negro, A., Facci, L., and Giusti, P. Neurotrophins rescue cerebellar granule neurons from oxidative stress-mediated apoptotic death: Selective involvement of phosphatidylinositol 3-kinase and the mitogen-activated protein kinase pathway. J. Neurochem., 70: 1859-1868, 1998
36. Klocker, N., Kermer, P., Weishaupt, J. H., Labes, M., Ankerhold, R., and Bahr, M. Brain-derived neurotrophic factor-mediated neuroprotection of adult rat retinal ganglion cells in vivo does not exclusively depend on phosphatidyl-inositol-3′-kinase/protein kinase B signaling. J. Neurosci., 20: 6962-6967, 2000
37. Encinas, M., Iglesias, M., Llecha, N., and Comella, J. X. Extracellular-regulated kinases and phosphatidylinositol 3-kinase are involved in brain-derived neurotrophic factor-mediated survival and neuritogenesis of the neuroblastoma cell line SH-SY5Y. J. Neurochem., 73: 1409-1421, 1999
38. Evans, A. E., Kisselbach, K. D., Liu, X., Eggert, A., Ikegaki, N., Camoratto, A. M., Dionne, C., and Brodeur, G. M. Effect of CEP-751 (KT-6587) on neuroblastoma xenografts expressing TrkB. Med. Pediatr. Oncol., 36: 181-184, 2001
39. Khanna, C., Jaboin, J., Drakos, E., Tsokos, M., and Thiele, C. J. Biologically relevant orthotopic neuroblastoma xenograft models: Primary adrenal tumor growth and spontaneous distant metastasis. In Vivo. 16: 77-85, 2002
40. Hu, L., Hofmann, J., Lu, Y., Mills, G. B., and Jaffe, R. B. Inhibition of phosphatidylinositol 3′-kinase increases efficacy of Paclitaxel in in vitro and in vivo ovarian cancer models. Cancer Res., 62: 1087-1092, 2002